Downregulation of SERPINE1 has been shown to have an inhibitory effect on EMT, whereas high levels have been identified as a potential biomarker for EMT in gastric cancer (Yang et al. 2019; Xu et al. 2019). This evidence concerns the gene SERPINE1 and gastric cancer.